Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
NOTE: This survey was conducted prior to the COVID-19 pandemic.
By Leanne Bronold, Clinical Guidelines Manager, Genex Services
Claims organizations continue to build and enhance their global digitization strategies, especially in the midst of the COVID-19 pandemic.
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the